glp 1 receptor agonist mechanism of action Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Mechanism of action of GLP-1

doi:10.1016/j.atherosclerosis.2012.09.012 151

MP Biomedicals, Solon, OH) for 812 days (45 animals/cage)

The development of insulin resistance is associated with a variety of factors, including obesity, genetic background, and defects in insulin signaling pathways (Saisho, 2015)

[DOI] [PubMed] [Google Scholar] 17.Malhotra A, Grunstein RR, Fietze I, Weaver TE, Redline S, Azarbarzin A, et al

DOI: 10.5694/mja2.70026 Acknowledgements: Luke Grzeskowiak receives salary support from a Channel 7 Childrens Research Foundation Fellowship (CRF-210323)

Glucagon-like peptide-1 receptor agonists and capsule endoscopy in patients with diabetes: a matched cohort study